SUBSCRIBE
SUBSCRIBE

Elutia

NEWS
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
 · 
1 min read
IN THE PRESS
Business
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
March 7, 2024
 · 
15 min read
Business
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
February 22, 2024
 · 
1 min read
BioCapital
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
December 18, 2023
 · 
6 min read
BioCapital
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
November 9, 2023
 · 
5 min read
Business
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
November 6, 2023
 · 
1 min read
BioCapital
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
September 20, 2023
 · 
1 min read
BioCapital
Elutia Announces Private Placement for Proceeds Up to $26 Million
September 19, 2023
 · 
7 min read
BioCapital
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
September 18, 2023
 · 
6 min read
BioCapital
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 8, 2023
 · 
1 min read
Business
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
September 6, 2023
 · 
5 min read
Load More
JOBS